Results 11 to 20 of about 59,312 (337)

Heartburn Center Set-Up in a Community Setting: Engineering and Execution

Frontiers in Medicine, 2021
Background: Optimal management of gastroesophageal reflux disease (GERD) requires a concerted team of physicians rather than an individual approach. While an integrated approach to GERD has previously been proposed, the practical execution of such a ...
Atul Maini, John Sun, Borys Buniak, Stacey Jantsch, Rachel Czajak, Tara Frey, B. Siva Kumar, Amarpreet Chawla   +7 more
doaj   +1 more source

Refractory heartburn [PDF]

Gastroenterology, 2003
Peter J. Kahrilas
openalex   +3 more sources

Poliprotect vs Omeprazole in the Relief of Heartburn, Epigastric Pain, and Burning in Patients Without Erosive Esophagitis and Gastroduodenal Lesions: A Randomized, Controlled Trial

American Journal of Gastroenterology, 2023
INTRODUCTION: In the treatment of upper GI endoscopy-negative patients with heartburn and epigastric pain or burning, antacids, antireflux agents, and mucosal protective agents are widely used, alone or as add-on treatment, to increase response to proton-
E. Corazziari, A. Gasbarrini, L. D'alba, V. D’Ovidio, O. Riggio, S. Passaretti, B. Annibale, M. Cicala, A. Repici, G. Bassotti, C. Ciacci, A. Di Sabatino, M. Neri, M. Bragazzi, E. Ribichini, G. Radocchia, P. Iovino, M. Marazzato, S. Schippa, D. Badiali   +19 more
semanticscholar   +1 more source

Multicenter study of gastroesophageal reflux disease symptoms prevalence in outpatients in Russia

Терапевтический архив, 2022
Background. Recently, there has been an increase in the prevalence of gastroesophageal reflux disease (GERD) in Northern Europe, North America and East Asia. However data on GERD prevalence in Russian population are very limited. Aim. To determine the
Dmitry S. Bordin, Rustam А. Abdulkhakov, Marina F. Osipenko, Alla V. Solovyeva, Sayar R. Abdulkhakov, Nikolay P. Kirilenko, Mikhail A. Butov, Olga I. Berezina, Elen R. Valitova, Dilyara D. Safina, Ilmira M. Alieva, Maria A. Livzan, Aiman S. Sarsenbaeva, Galina N. Tarasova, Yulia V. Embutnieks, Indira R. Mubarakshina, Ilshat Kh. Khayrullin, Alla G. Kononova, Sergey V. Kolbasnikov, Igor V. Maev   +19 more
doaj   +1 more source

Effects of Tegoprazan Versus Esomeprazole on Nighttime Heartburn and Sleep Quality in Gastroesophageal Reflux Disease: A Multicenter Double-blind Randomized Controlled Trial

Journal of Neurogastroenterology and Motility, 2022
Background/Aims Patients with gastroesophageal reflux disease (GERD) frequently experience nighttime heartburn and sleep disturbance. Tegoprazan is a new potassium-competitive acid blocker that can rapidly block acid secretion.
J. Kim, S. Seo, S. Kang, Sang Kil Lee, A. R. Kim, Hyun Wook Park, Bongtae Kim, G. Song   +7 more
semanticscholar   +1 more source

Phenotypes of gastroesophageal reflux disease: classification, pathogenesis and diagnostic criteria: A review

Consilium Medicum, 2022
The literature review focuses on the current understanding of visceral hypersensitivity mechanisms in the esophagus. Mechanisms of peripheral and central sensitization and their relation to heartburn symptoms are covered in detail.
Igor V. Maev, Elena V. Barkalova, Mariia A. Ovsepian, Dmitry N. Andreev   +3 more
doaj   +1 more source

Heartburn Sensation in Non-Erosive Reflux Disease: Pattern of Superficial Sensory Nerves Expressing TRPV1 and Epithelial Cells Expressing ASIC3 Receptors.

American Journal of Physiology - Gastrointestinal and Liver Physiology, 2021
The underlying causes of heartburn, characteristic symptom of gastro-esophageal reflux disease(GERD), remain incompletely understood. Superficial afferent innervation of the esophageal mucosa in nonerosive reflux disease(NERD) may drive nociceptive ...
A. Ustaoglu, Akinari Sawada, Chung Lee, W. Lei, Chien‐Lin Chen, R. Hackett, D. Sifrim, M. Peiris, P. Woodland   +8 more
semanticscholar   +1 more source

Sleep disruption due to nocturnal heartburn: a review of the evidence and clinical implications

Exploration of Medicine, 2023
Nocturnal heartburn (NHB) is a symptom that affects up to 25% of the general population and has been shown to cause sleep disruption that adversely affects quality of life and psychomotor performance.
David A. Johnson, Amisha M. Parikh-Das, Evren Atillasoy, Hayk Davtyan, Leslie Shur, Andrea S. Blevins-Primeau, Nathaniel F. Watson   +6 more
doaj   +1 more source

Heartburn in children and adolescents in the presence of functional dyspepsia and/or irritable bowel syndrome correlates with the presence of sleep disturbances, anxiety, and depression

Medicine, 2021
The aim of this study was to assess the relationship of heartburn in pediatric patients with functional dyspepsia (FD) and irritable bowel syndrome (IBS) with gastrointestinal symptoms, sleep disturbances, and psychologic distress.
J. Colombo, Amanda D. Deacy, J. Schurman, C. Friesen   +3 more
semanticscholar   +1 more source

First‐Line Osimertinib in Patients with EGFR‐Mutant Advanced Non‐Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

The Oncologist, EarlyView., 2021
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi, Alessandra Ferro, Fabiana Cecere, Daniela Scattolin, Alessandro Del Conte, Alessandro Follador, Sara Pilotto, Valentina Polo, Mariacarmela Santarpia, Rita Chiari, Alberto Pavan, Alessandro Dal Maso, Valentina Da Ros, Giada Targato, Sabrina Vari, Stefano Indraccolo, Fiorella Calabrese, Stefano Frega, Laura Bonanno, Pier Franco Conte, Valentina Guarneri, Giulia Pasello   +21 more
wiley   +1 more source